DNA methylation inhibition in myeloma: Experience from a phase 1b study of low-dose continuous azacitidine in combination with lenalidomide and low-dose dexamethasone in relapsed or refractory multiple myeloma
| Autor: | Khouri, Jack, Faiman, Beth M, Grabowski, Dale, Mahfouz, Reda Z, Khan, Shahper N, Wei, Wei, Valent, Jason, Dean, Robert, Samaras, Christy, Jha, Babal K, Lazarus, Hillard, Campagnaro, Erica L., Malek, Ehsan, Reed, Janice, Karam, Mary Ann, Hamilton, Kimberly, Fada, Sherry, Kalaycio, Matt, Liu, Hien, Sobecks, Ronald, Saunthararajah, Yogen, Chew, Yap, Orloff, Mohammed, Reu, Frederic J |
|---|---|
| Zdroj: | In Seminars in Hematology January 2021 58(1):45-55 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|